South Korea General Anesthesia Market to Grow at a CAGR of 4.5% During 2024-2032, Aided by Rising Surgical Procedures and Diagnostic Interventions

The general anesthesia market in South Korea is experiencing significant growth, fuelled by a growing consumer preference for safe and effective anesthesia during surgeries. This trend is driven by a heightened awareness of general anesthesia's benefits, such as complete unconsciousness, pain management, and muscle relaxation. This shift in patient preference has significantly increased demand for general anesthesia procedures, propelling the market forward.

Further, the market is influenced by the advancements in the pharmaceutical industry. Companies in the sector such as Pfizer Inc. (NYSE: PFE) continuously strive to develop novel and improved anesthesia drugs.  These medications ideally possess fewer side effects, faster acting mechanisms, and promote quicker recovery times for patients. This relentless pursuit of innovation in drug development by pharmaceutical companies plays a significant role in shaping the South Korea general anesthesia market dynamics.

Fuelled by a growing elderly population, a rise in chronic illnesses, and advancements in surgical techniques, the market is experiencing significant demand. General anesthesia plays a vital role in a wide range of surgical procedures, from common operations like gallbladder removal and hernia repair to intricate interventions like heart surgery and organ transplants. This underscores general anesthesia's critical role in enabling safe and effective surgical care across a spectrum of complexities.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Drug Type, Route of Administration, Surgery Type, and End-Use:

• On the basis of the drug type, the market is divided into propofol, sevoflurane, desflurane, and dexmedetomidine, among others.

• The market can be segmented based on the route of administration into intravenous and inhalation.

• On the basis of the surgery type, the market is divided into heart surgery, cancer surgery, knee and hip replacements, and general surgery, among others.

• The market can be segmented based on end-use into hospitals and ambulatory surgical centres.

Key Findings of the Report:

• The South Korea general anesthesia market expansion can be attributed to the development and widespread use of advanced anesthesia delivery systems. These systems, which include anesthesia machines equipped with integrated monitoring and alarm functions, alongside advanced ventilation modes, have demonstrably improved patient safety and streamlined the entire anesthesia administration process.

• The increasing number of outpatient surgeries signifies a shift towards less complex procedures, and the growing popularity of minimally invasive surgeries minimises patient recovery time. These factors create a strong demand for short-acting anesthetic agents, essential for efficient outpatient surgeries and faster post-operative recovery.

• South Korea's rapidly ageing population presents a unique challenge for its healthcare system. The growing number of elderly individuals, often accompanied by an increase in chronic diseases, necessitates a corresponding rise in medical procedures. This trend directly translates to a heightened demand for anesthetic medications to ensure safe and effective surgical interventions.

Key Offerings of the Report:

• The EMR report gives an overview of the South Korea general anesthesia market for the periods (2017-2023) and (2024-2032).

• The report also offers historical (2017-2023) and forecast (2024-2032) market information for drug types, routes of administration, surgery types, and end uses of general anesthetia in South Korea.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the South Korea general anesthesia market are Fresenius Kabi Korea Ltd, Hana Pharm Co., Ltd., Daewon Pharmaceutical Co., Ltd, Pfizer Ltd., Baxter International Inc., and AbbVie Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

Key Highlights of the Report

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.